These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31302763)

  • 1. Brexanolone and postpartum depression: what does it have to do with GABA?
    Naguy A
    Arch Womens Ment Health; 2019 Dec; 22(6):833-834. PubMed ID: 31302763
    [No Abstract]   [Full Text] [Related]  

  • 2. Brexanolone Therapy for Postpartum Depression.
    Shabbir O; Khan KS; Jawaid H
    J Pak Med Assoc; 2020 Mar; 70(3):565-566. PubMed ID: 32207453
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development.
    Frieder A; Fersh M; Hainline R; Deligiannidis KM
    CNS Drugs; 2019 Mar; 33(3):265-282. PubMed ID: 30790145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience.
    Lüscher B; Möhler H
    F1000Res; 2019; 8():. PubMed ID: 31275559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating postpartum depression with brexanolone.
    Burval J; Kerns R; Reed K
    Nursing; 2020 May; 50(5):48-53. PubMed ID: 32332506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brexanolone for the treatment of patients with postpartum depression.
    Morrison KE; Cole AB; Thompson SM; Bale TL
    Drugs Today (Barc); 2019 Sep; 55(9):537-544. PubMed ID: 31584571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brexanolone For Postpartum Depression: A Novel Approach and a Call for Comprehensive Postpartum Care.
    Jarman AF; MacLean JV; Barron RJ; Wightman RS; McGregor AJ
    Clin Ther; 2020 Jan; 42(1):231-235. PubMed ID: 31910998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US Food and Drug Administration approval of esketamine and brexanolone.
    Cristea IA; Naudet F
    Lancet Psychiatry; 2019 Dec; 6(12):975-977. PubMed ID: 31680013
    [No Abstract]   [Full Text] [Related]  

  • 9. Brexanolone Is the First Drug Specifically for Postpartum Depression.
    Fantasia HC
    Nurs Womens Health; 2019 Oct; 23(5):450-454. PubMed ID: 31445988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeing the whole picture of postpartum depression.
    The Lancet Psychiatry
    Lancet Psychiatry; 2019 Jul; 6(7):547. PubMed ID: 31230672
    [No Abstract]   [Full Text] [Related]  

  • 11. Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression.
    Powell JG; Garland S; Preston K; Piszczatoski C
    Ann Pharmacother; 2020 Feb; 54(2):157-163. PubMed ID: 31476884
    [No Abstract]   [Full Text] [Related]  

  • 12. Brexanolone for postpartum depression: A meta-analysis of randomized controlled studies.
    Zheng W; Cai DB; Zheng W; Sim K; Ungvari GS; Peng XJ; Ning YP; Wang G; Xiang YT
    Psychiatry Res; 2019 Sep; 279():83-89. PubMed ID: 31323375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
    Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S
    Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and Newborn Safety During the Administration of Brexanolone: AWHONN Practice Brief Number 10.
    Association of Women’s Health, Obstetric and Neonatal Nurses
    J Obstet Gynecol Neonatal Nurs; 2020 Nov; 49(6):620-621. PubMed ID: 33069498
    [No Abstract]   [Full Text] [Related]  

  • 15. Not So Fast: Recent Successes and Failures in Treating Depression.
    Kadriu B; Deng ZD; Kraus C; Henter ID; Lisanby SH; Zarate CA
    J Clin Psychiatry; 2020 May; 81(4):. PubMed ID: 32459405
    [No Abstract]   [Full Text] [Related]  

  • 16. Brexanolone for postpartum depression.
    Hutcherson TC; Cieri-Hutcherson NE; Gosciak MF
    Am J Health Syst Pharm; 2020 Feb; 77(5):336-345. PubMed ID: 32073124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Neurobiology to Novel Medications: A Principled Approach to Translation.
    Gordon JA
    Am J Psychiatry; 2019 Jun; 176(6):425-427. PubMed ID: 31154816
    [No Abstract]   [Full Text] [Related]  

  • 18. Brexanolone (Zulresso) for postpartum depression.
    Med Lett Drugs Ther; 2019 May; 61(1571):68-70. PubMed ID: 31169804
    [No Abstract]   [Full Text] [Related]  

  • 19. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
    Kanes SJ; Colquhoun H; Doherty J; Raines S; Hoffmann E; Rubinow DR; Meltzer-Brody S
    Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28370307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.
    Leader LD; O'Connell M; VandenBerg A
    Pharmacotherapy; 2019 Nov; 39(11):1105-1112. PubMed ID: 31514247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.